- Home
- OKLO vs ZLAB Comparison
OKLO vs ZLAB Comparison
Compare OKLO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKLO
- ZLAB
- Stock Information
- Founded
- OKLO 2013
- ZLAB 2013
- Country
- OKLO United States
- ZLAB China
- Employees
- OKLO N/A
- ZLAB N/A
- Industry
- OKLO
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- OKLO
- ZLAB Health Care
- Exchange
- OKLO NYSE
- ZLAB Nasdaq
- Market Cap
- OKLO 3.1B
- ZLAB 3.5B
- IPO Year
- OKLO N/A
- ZLAB 2017
- Fundamental
- Price
- OKLO $28.11
- ZLAB $29.24
- Analyst Decision
- OKLO Buy
- ZLAB Buy
- Analyst Count
- OKLO 6
- ZLAB 4
- Target Price
- OKLO $46.40
- ZLAB $47.37
- AVG Volume (30 Days)
- OKLO 9.7M
- ZLAB 1.2M
- Earning Date
- OKLO 05-13-2025
- ZLAB 05-08-2025
- Dividend Yield
- OKLO N/A
- ZLAB N/A
- EPS Growth
- OKLO N/A
- ZLAB N/A
- EPS
- OKLO N/A
- ZLAB N/A
- Revenue
- OKLO N/A
- ZLAB $418,326,000.00
- Revenue This Year
- OKLO N/A
- ZLAB $44.43
- Revenue Next Year
- OKLO N/A
- ZLAB $48.68
- P/E Ratio
- OKLO N/A
- ZLAB N/A
- Revenue Growth
- OKLO N/A
- ZLAB 43.72
- 52 Week Low
- OKLO $5.35
- ZLAB $15.65
- 52 Week High
- OKLO $59.14
- ZLAB $39.77
- Technical
- Relative Strength Index (RSI)
- OKLO 58.45
- ZLAB 42.71
- Support Level
- OKLO $24.53
- ZLAB $27.61
- Resistance Level
- OKLO $28.97
- ZLAB $32.02
- Average True Range (ATR)
- OKLO 1.91
- ZLAB 1.23
- MACD
- OKLO 0.70
- ZLAB -0.18
- Stochastic Oscillator
- OKLO 89.74
- ZLAB 23.41
About OKLO OKLO INC
Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.